755303
3-Amino-2-fluoropropionic acid
95%
Synonym(s):
DL-2-Fluoro-β-alanine
Sign Into View Organizational & Contract Pricing
All Photos(1)
About This Item
Recommended Products
Assay
95%
form
solid
mp
240-245 °C
SMILES string
NCC(F)C(O)=O
InChI
1S/C3H6FNO2/c4-2(1-5)3(6)7/h2H,1,5H2,(H,6,7)
InChI key
OJQNRNQELNLWHH-UHFFFAOYSA-N
Related Categories
Signal Word
Danger
Hazard Statements
Precautionary Statements
Hazard Classifications
Acute Tox. 4 Oral - Eye Dam. 1 - Skin Irrit. 2 - STOT SE 3
Target Organs
Respiratory system
Storage Class Code
11 - Combustible Solids
WGK
WGK 3
Flash Point(F)
Not applicable
Flash Point(C)
Not applicable
Certificates of Analysis (COA)
Search for Certificates of Analysis (COA) by entering the products Lot/Batch Number. Lot and Batch Numbers can be found on a product’s label following the words ‘Lot’ or ‘Batch’.
Already Own This Product?
Find documentation for the products that you have recently purchased in the Document Library.
Customers Also Viewed
Anti-cancer drugs, 15(10), 969-974 (2004-10-30)
Capecitabine (Xeloda) is a very active oral fluoropyrimidine (colon and breast cancers) whose clinical use is complicated by the presence of hand-foot syndrome (HFS). This cutaneous toxicity is less frequently encountered with other oral fluoropyrimidines containing a dihydropyrimidine dehydrogenase (DPD)
British journal of clinical pharmacology, 55(3), 252-263 (2003-03-13)
To assess the relationship between systemic exposure to capecitabine metabolites and parameters of efficacy and safety in patients with advanced or metastatic colorectal cancer from two phase III studies. Concentration-effect analyses were based on data from 481 patients (248 males
The Journal of toxicological sciences, 29(2), 155-166 (2004-06-23)
In order to clarify the mechanism of the neurotoxicity of 5-FU and/or its masked compounds, we studied the effects of alpha-fluoro-beta-alanine (FBAL) and fluoroacetic acid (FA) on the formation of vacuolar changes in the dog cerebrum, using the dosage of
Cancer chemotherapy and pharmacology, 42(4), 341-344 (1998-09-23)
The aim of this study was to identify the route of administration of 5-FU with the greatest pharmacological advantage in a rat model using non-invasive in vivo 19F nuclear magnetic resonance (NMR) spectroscopy. 5-FU (50 mg/kg) was administered to anesthetized
Cancer chemotherapy and pharmacology, 52(3), 193-201 (2003-06-05)
Capecitabine (Xeloda) is a novel, oral fluoropyrimidine carbamate rationally designed to generate 5-fluorouracil (5-FU) preferentially in tumor tissue via a three-step enzymatic cascade. The objective of this study was to compare the pharmacokinetics of capecitabine and its metabolites in Japanese
Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.
Contact Technical Service